Pharma Journalist -

Eli Lilly and Company and Verve Therapeutics, Inc., a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease, announced a definitive agreement for…
Read More...

Lisata Therapeutics, Inc. and GATC Health Corp. announced a strategic alliance designed to accelerate and improve the success rate of the traditional drug development process. This…
Read More...

Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs Orion Corporation and Glykos Finland Oy…
Read More...

Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), announced an international collaboration with…
Read More...

The 2025 summit offers an in-depth look at the most innovative technologies and scientific strategies shaping the future of microbiome-based therapies. This includes advancements in…
Read More...

Global pharma major Lupin Limited (Lupin) announced that it has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP), for the commercialization of Tiotropium…
Read More...

Celltrion, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA (ustekinumab-stba), a biosimilar to STELARA (ustekinumab), in a…
Read More...

NextCure, Inc. has announced a strategic collaboration with Simcere Zaiming, an oncology-focused subsidiary of Simcere Pharmaceutical Group Ltd. The partnership centers on the…
Read More...

Teva Pharmaceutical Industries Ltd. and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that the companies, through their respective subsidiaries, have entered a strategic…
Read More...

Averoa announced that the European Commission (EC) has granted marketing authorization for XOANACYL. This follows the positive opinion issued in March by the committee for Medicinal…
Read More...